Published in Part Fibre Toxicol on March 03, 2010
Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci U S A (2011) 1.21
Magnetic Nanoparticles in Cancer Theranostics. Theranostics (2015) 1.20
Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev (2011) 1.09
Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Part Fibre Toxicol (2010) 1.07
Sustained-release nanoART formulation for the treatment of neuroAIDS. Int J Nanomedicine (2015) 1.07
Suppression of nuclear factor-κB activation and inflammation in microglia by physically modified saline. J Biol Chem (2012) 1.06
Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano (2013) 1.03
Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine (2014) 1.02
Protection of Tregs, suppression of Th1 and Th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline. PLoS One (2012) 0.97
Photoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivo. J Biophotonics (2013) 0.94
Targeted imaging and therapy of brain cancer using theranostic nanoparticles. Mol Pharm (2010) 0.94
Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement. Chem Cent J (2014) 0.89
Nanotechnology: toxicologic pathology. Toxicol Pathol (2013) 0.87
Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid. Biochim Biophys Acta (2013) 0.87
A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy. PLoS One (2012) 0.86
The nanomedicine revolution: part 2: current and future clinical applications. P T (2012) 0.85
Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors. J Biomed Sci (2012) 0.84
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier. Pharmaceutics (2014) 0.83
The nanomedicine revolution: part 1: emerging concepts. P T (2012) 0.83
SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain. J Alzheimers Dis (2013) 0.82
Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system. Int J Nanomedicine (2014) 0.81
Effect of magnetic nanoparticles on tobacco BY-2 cell suspension culture. Int J Environ Res Public Health (2012) 0.80
Integration of biosensors and drug delivery technologies for early detection and chronic management of illness. Sensors (Basel) (2013) 0.79
Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery. PLoS One (2013) 0.79
Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound. Neuropharmacology (2016) 0.79
Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models. Pharm Res (2014) 0.78
New clathrin-based nanoplatforms for magnetic resonance imaging. PLoS One (2012) 0.78
The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain. Int J Mol Sci (2016) 0.78
Multi-stimuli responsive Cu2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agents. Nanoscale (2015) 0.78
Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease. Curr Neuropharmacol (2016) 0.78
The current state of engineered nanomaterials in consumer goods and waste streams: the need to develop nanoproperty-quantifiable sensors for monitoring engineered nanomaterials. Nanotechnol Sci Appl (2011) 0.77
A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study. J Nanobiotechnology (2014) 0.77
Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma. J Control Release (2015) 0.76
Multi-Functionality in Theranostic Nanoparticles: is more Always Better? J Nanomed Nanotechnol (2012) 0.76
Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier. Int J Nanomedicine (2016) 0.76
Cancer optical imaging using fluorescent nanoparticles. Nanomedicine (Lond) (2011) 0.76
GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases. J Cell Mol Med (2015) 0.76
Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform. J Biophotonics (2015) 0.76
The Use of Anthracyclines for Therapy of CNS Tumors. Anticancer Agents Med Chem (2015) 0.75
Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting. Drug Des Devel Ther (2017) 0.75
Vectorized nanodelivery systems for ischemic stroke: a concept and a need. J Nanobiotechnology (2017) 0.75
Monosialoganglioside-Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins. J Am Heart Assoc (2016) 0.75
Efficiency of calcium phosphate composite nanoparticles in targeting Ehrlich carcinoma cells transplanted in mice. J Adv Res (2015) 0.75
Preparation of silica nanoparticles loaded with nootropics and their in vivo permeation through blood-brain barrier. Biomed Res Int (2015) 0.75
Editorial: Cancer Nanotheranostics: What Have We Learned So Far? Front Chem (2016) 0.75
Novel Strategies for the Improvement of Stem Cells' Transplantation in Degenerative Retinal Diseases. Stem Cells Int (2016) 0.75
Diagnostic and therapeutic potential of tetanus toxin-derivatives in neurological diseases. J Mol Neurosci (2013) 0.75
Emergent Properties and Toxicological Considerations for Nanohybrid Materials in Aquatic Systems. Nanomaterials (Basel) (2014) 0.75
Nanomedicine concepts in the general medical curriculum: initiating a discussion. Int J Nanomedicine (2015) 0.75
Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate. PLoS One (2017) 0.75
Development of multifunctional nanoparticles towards applications in non-invasive magnetic resonance imaging and axonal tracing. J Biol Inorg Chem (2017) 0.75
The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther (2017) 0.75
Toxic potential of materials at the nanolevel. Science (2006) 19.24
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Semiconductor nanocrystals as fluorescent biological labels. Science (1998) 16.68
Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat Biotechnol (2006) 14.96
Deep tissue two-photon microscopy. Nat Methods (2005) 14.95
Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science (1998) 14.44
Optical sectioning deep inside live embryos by selective plane illumination microscopy. Science (2004) 13.77
Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain. Nat Biotechnol (2003) 11.28
Imaging in the era of molecular oncology. Nature (2008) 11.10
Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol (1969) 10.33
Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol (1967) 9.74
Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol (2005) 9.57
Shedding light onto live molecular targets. Nat Med (2003) 8.47
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol (1999) 8.46
Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science (2003) 8.17
The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev (2005) 7.56
Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods (2001) 7.08
Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol (2008) 6.41
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06
Fluorescence molecular tomography resolves protease activity in vivo. Nat Med (2002) 5.53
The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov (2006) 5.11
Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev (2008) 4.80
Nanosilver: a nanoproduct in medical application. Toxicol Lett (2007) 3.88
Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis. Lancet (2008) 3.59
The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol (2006) 3.56
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology (1990) 3.50
Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. Opt Lett (2001) 3.43
Combined ultrasound and optoacoustic system for real-time high-contrast vascular imaging in vivo. IEEE Trans Med Imaging (2005) 3.19
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect (2006) 3.16
Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol (2006) 3.13
A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem (1999) 3.09
Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev (2001) 3.01
Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol (2000) 2.96
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater (2006) 2.84
Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express (2007) 2.84
Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A (2004) 2.77
MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia (2002) 2.68
Nanoparticle-based targeted drug delivery. Exp Mol Pathol (2009) 2.62
A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys (2003) 2.58
Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect (2006) 2.51
Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation (2005) 2.45
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx (2005) 2.44
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol (2005) 2.43
Receptor-mediated transport of insulin across endothelial cells. Science (1985) 2.42
Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev (2007) 2.38
Noninvasive label-free imaging of microhemodynamics by optical-resolution photoacoustic microscopy. Opt Express (2009) 2.34
Biodistribution of 1.4- and 18-nm gold particles in rats. Small (2008) 2.32
Initial results of in vivo non-invasive cancer imaging in the human breast using near-infrared photoacoustics. Opt Express (2007) 2.32
Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol (2003) 2.28
Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol (2006) 2.22
Nanoparticles for drug delivery in cancer treatment. Urol Oncol (2008) 2.21
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19
Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods (1982) 2.16
Strategies to advance translational research into brain barriers. Lancet Neurol (2008) 2.16
Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev (2004) 2.10
Multispectral photoacoustic imaging of fluorochromes in small animals. Opt Lett (2007) 2.04
Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med (2005) 2.03
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target (2002) 2.02
Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol (2006) 1.99
Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm (Vienna) (2006) 1.96
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther (2004) 1.96
The BARC biosensor applied to the detection of biological warfare agents. Biosens Bioelectron (2000) 1.92
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci U S A (2005) 1.91
Free-space fluorescence molecular tomography utilizing 360 degrees geometry projections. Opt Lett (2007) 1.91
Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol (2008) 1.87
Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol (2007) 1.81
RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther (2005) 1.79
In vivo imaging of Drosophila melanogaster pupae with mesoscopic fluorescence tomography. Nat Methods (2007) 1.78
Ultrafine particle-lung interactions: does size matter? J Aerosol Med (2006) 1.69
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res (1995) 1.68
Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release (2008) 1.66
Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest (2006) 1.58
Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology (2008) 1.56
Insulin-like growth factors cross the blood-brain barrier. Endocrinology (1994) 1.56
Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm (2008) 1.56
Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol (1998) 1.55
Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage (2008) 1.53
Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology (2005) 1.53
In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett (2008) 1.51
Barriers in the brain: a renaissance? Trends Neurosci (2008) 1.49
Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. J Biomed Opt (2001) 1.49
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev (2007) 1.48
Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs (2009) 1.47
Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther (2000) 1.46
Impaired transport of leptin across the blood-brain barrier in obesity. Peptides (1999) 1.46
Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro (2006) 1.43
Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem (1987) 1.42
shRNA and siRNA delivery to the brain. Adv Drug Deliv Rev (2007) 1.42
Structural and functional aspects of the blood-brain barrier. Prog Drug Res (2003) 1.42
Active targeting of brain tumors using nanocarriers. Biomaterials (2007) 1.42
Noninvasive functional imaging of human brain using light. J Cereb Blood Flow Metab (2000) 1.41
Preliminary experience with a novel intraoperative fluorescence imaging technique to evaluate the patency of bypass grafts in total arterial revascularization. Ann Thorac Surg (2003) 1.39
Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res (2005) 1.38
Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug Chem (2005) 1.37
Drug transport to brain with targeted nanoparticles. NeuroRx (2005) 1.37
Secondary active transport of water across ventricular cell membrane of choroid plexus epithelium of Necturus maculosus. J Physiol (1991) 1.36
Monkey brain cortex imaging by photoacoustic tomography. J Biomed Opt (2008) 1.34
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm (2008) 1.33
Deducing in vivo toxicity of combustion-derived nanoparticles from a cell-free oxidative potency assay and metabolic activation of organic compounds. Environ Health Perspect (2008) 1.32
Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res (2008) 1.32
Shedding light onto live molecular targets. Nat Med (2003) 8.47
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med (2011) 7.82
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol (2005) 6.04
Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect (2005) 3.57
The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol (2006) 3.56
Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A (2002) 3.49
In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62
A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys (2003) 2.58
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation (2006) 2.56
Evaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential--a workshop report and consensus statement. Inhal Toxicol (2008) 2.53
Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52
Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med (2011) 2.44
Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt (2010) 2.34
Molecular imaging by means of multispectral optoacoustic tomography (MSOT). Chem Rev (2010) 2.27
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19
Volumetric tomography of fluorescent proteins through small animals in vivo. Proc Natl Acad Sci U S A (2005) 2.16
Accuracy of fluorescent tomography in the presence of heterogeneities: study of the normalized Born ratio. IEEE Trans Med Imaging (2005) 2.15
Multispectral photoacoustic imaging of fluorochromes in small animals. Opt Lett (2007) 2.04
Epidemiological evidence on health effects of ultrafine particles. J Aerosol Med (2002) 2.00
Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proc Natl Acad Sci U S A (2008) 2.00
Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett (2005) 1.94
Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. J Biomed Opt (2008) 1.93
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci U S A (2005) 1.91
Free-space fluorescence molecular tomography utilizing 360 degrees geometry projections. Opt Lett (2007) 1.91
Tomographic fluorescence mapping of tumor targets. Cancer Res (2005) 1.89
Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol (2002) 1.83
Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography. Radiology (2012) 1.81
In vivo imaging of Drosophila melanogaster pupae with mesoscopic fluorescence tomography. Nat Methods (2007) 1.78
Volumetric real-time multispectral optoacoustic tomography of biomarkers. Nat Protoc (2011) 1.78
Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms. ACS Nano (2014) 1.75
Genomewide linkage analysis identifies novel genetic Loci for lung function in mice. Am J Respir Crit Care Med (2005) 1.67
Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomography. J Opt Soc Am A Opt Image Sci Vis (2004) 1.65
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med (2011) 1.62
Experimental fluorescence tomography of tissues with noncontact measurements. IEEE Trans Med Imaging (2004) 1.62
Hybrid system for simultaneous fluorescence and x-ray computed tomography. IEEE Trans Med Imaging (2009) 1.62
Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol (2011) 1.60
Toxicological hazards of inhaled nanoparticles--potential implications for drug delivery. J Nanosci Nanotechnol (2004) 1.59
The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol (2007) 1.56
Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med (2011) 1.54
Fast semi-analytical model-based acoustic inversion for quantitative optoacoustic tomography. IEEE Trans Med Imaging (2010) 1.52
Multispectral imaging using multiple-bandpass filters. Opt Lett (2008) 1.52
Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake. ACS Nano (2012) 1.51
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Eur J Pharm Biopharm (2010) 1.49
Time-resolved imaging of optical coefficients through murine chest cavities. J Biomed Opt (2007) 1.46
Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology (2007) 1.45
FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography. Nat Methods (2012) 1.44
Intravascular near-infrared fluorescence molecular imaging of atherosclerosis: toward coronary arterial visualization of biologically high-risk plaques. J Biomed Opt (2010) 1.42
Effects of ultrafine and fine particulate and gaseous air pollution on cardiac autonomic control in subjects with coronary artery disease: the ULTRA study. J Expo Sci Environ Epidemiol (2005) 1.42
Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol (2011) 1.41
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes (2006) 1.39
High-sensitivity compact ultrasonic detector based on a pi-phase-shifted fiber Bragg grating. Opt Lett (2011) 1.35
Fluorescent protein tomography scanner for small animal imaging. IEEE Trans Med Imaging (2005) 1.34
Multispectral optoacoustic tomography (MSOT) scanner for whole-body small animal imaging. Opt Express (2009) 1.30
Real-time imaging of cardiovascular dynamics and circulating gold nanorods with multispectral optoacoustic tomography. Opt Express (2010) 1.30
Complete-angle projection diffuse optical tomography by use of early photons. Opt Lett (2005) 1.30
Free-space propagation of diffuse light: theory and experiments. Phys Rev Lett (2003) 1.28
Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology (2003) 1.28
Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J (2009) 1.28
Compressive sensing for biomedical imaging. IEEE Trans Med Imaging (2011) 1.27
Gold glyconanoparticles as new tools in antiadhesive therapy. Chembiochem (2004) 1.25
Video rate optoacoustic tomography of mouse kidney perfusion. Opt Lett (2010) 1.25
Noncontact optical imaging in mice with full angular coverage and automatic surface extraction. Appl Opt (2007) 1.23
Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation (2004) 1.22
Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol (2005) 1.22
Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques. Mol Imaging Biol (2012) 1.22
Development of fluorescent materials for Diffuse Fluorescence Tomography standards and phantoms. Opt Express (2007) 1.22
Performance dependence of hybrid x-ray computed tomography/fluorescence molecular tomography on the optical forward problem. J Opt Soc Am A Opt Image Sci Vis (2009) 1.20
Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers. Biomaterials (2006) 1.20
Hybrid photoacoustic fluorescence molecular tomography using finite-element-based inversion. Med Phys (2007) 1.19
Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt Lett (2002) 1.19
Daily mortality and particulate matter in different size classes in Erfurt, Germany. J Expo Sci Environ Epidemiol (2006) 1.18
Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia (2003) 1.18
Optimization of 360 degrees projection fluorescence molecular tomography. Med Image Anal (2007) 1.18
Normalized Born ratio for fluorescence optical projection tomography. Opt Lett (2009) 1.17
Fluorescence molecular tomography in the presence of background fluorescence. Phys Med Biol (2006) 1.16
Noncontact optical tomography of turbid media. Opt Lett (2003) 1.16
Three-dimensional optoacoustic tomography using a conventional ultrasound linear detector array: whole-body tomographic system for small animals. Med Phys (2013) 1.16
Three-dimensional in vivo imaging of green fluorescent protein-expressing T cells in mice with noncontact fluorescence molecular tomography. Mol Imaging (2007) 1.15
Real-time handheld multispectral optoacoustic imaging. Opt Lett (2013) 1.15
Comparison of fluorescence tomographic imaging in mice with early-arriving and quasi-continuous-wave photons. Opt Lett (2010) 1.15
Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. J Appl Physiol (1985) (2008) 1.15
Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. Chemistry (2003) 1.14
Hybrid FMT-CT imaging of amyloid-beta plaques in a murine Alzheimer's disease model. Neuroimage (2008) 1.14
Imaging performance of a hybrid x-ray computed tomography-fluorescence molecular tomography system using priors. Med Phys (2010) 1.13
Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer. Proc Natl Acad Sci U S A (2013) 1.13
Multispectral opto-acoustic tomography (MSOT) of the brain and glioblastoma characterization. Neuroimage (2012) 1.12
Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography. J Biomed Opt (2005) 1.12
Concentration response functions for ultrafine particles and all-cause mortality and hospital admissions: results of a European expert panel elicitation. Environ Sci Technol (2010) 1.12
Deep-tissue reporter-gene imaging with fluorescence and optoacoustic tomography: a performance overview. Mol Imaging Biol (2014) 1.11